The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of ...

Noida: A native of Kazakhstan, who had been experiencing locomotor disability for the last 14 years, as a side effect of ...

Researchers studying brain waves have suggested that a new discovery they have made could hold the key to treating anxiety in people diagnosed with P ...

For the one million people diagnosed with Parkinson's disease in the United States1, Medtronic plc (NYSE:MDT), a global ...

Medtronic gets US FDA nod for the world’s first adaptive deep brain stimulation system for people with Parkinson’s disease: Galway, Ireland Saturday, March 1, 2025, 09:00 Hrs ...

For the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...

There is no cure for Parkinson's, and over one million people have the disease in the United States alone. However, deep brain stimulation (DBS) has been used to treat this and other neurological ...

The FDA has approved Medtronic's Brainsense Adaptive deep brain stimulation for patients with Parkinson's disease. The technology is designed to adjust therapy in real time based on a patient's brain ...

Researchers at MIT have discovered that exposing the brain to light and sound pulses at a specific frequency—40 hertz, or 40 cycles per second—can induce brain rhythms that reduce the hallmark ...